EUVIMEDAtrasti EUVIMED
Multizentrische Studie

Efficacy of the Bonebridge BCI602 for Adult Patients with Single‐sided Deafness: A Prospective Multicenter Study

Hantai Kim iD, Moo Kyun Park iD, Shi Nae Park iD, Hyong-Ho Cho iD, Jae Young Choi iD, Chi Kyou Lee iD, Il-Woo Lee, Il Joon Moon iD, Jae Yun Jung iD, Jinsei Jung iD, Kyu-Yup Lee, Jeong-Hoon Oh and 6 more

Otolaryngology–Head and Neck Surgery · 2024

DOI: 10.1002/ohn.520 ↗

At a glance

Multizentrische Studie in Otolaryngology–Head and Neck Surgery, 2024. Written by Hantai Kim and 17 co-authors. Institution: Department of Otorhinolaryngology-Head and Neck Surgery, Konyang University College of Medicine, Daejeon, Korea. Major MEDLINE topics: Deafness, Hearing Aids, Tinnitus, Speech Perception. Cited 9 times so far (Crossref); 62 references.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Objective

To investigate the safety and efficacy of a novel active transcutaneous bone conduction implant (BCI) device for patients with single‐sided deafness (SSD). Study Design Prospective cohort study.

Setting

Tertiary referral hospitals.

Methods

This prospective multicenter study was conducted at 15 institutions nationwide. Thirty adult (aged ≥19 years) SSD patients were recruited. They underwent implantation of an active transcutaneous BCI device (Bonebridge BCI602). Objective outcomes included aided pure‐tone thresholds, aided speech discrimination scores (SDSs), and the Hearing in Noise Test (HINT) and sound localization test results. The Bern Benefit in Single‐Sided Deafness (BBSS) questionnaire, the Abbreviated Profile of Hearing Aid Benefit (APHAB) questionnaire, and the Tinnitus Handicap Inventory (THI) were used to measure subjective benefits.

Results

The mean aided pure‐tone threshold was 34.2 (11.3), mean (SD), dB HL at 500 to 4000 Hz. The mean total BBSS score was 27.5 (13.8). All APHAB questionnaire domain scores showed significant improvements: ease of communication, 33.6 (23.2) versus 22.6 (21.3), P = .025; reverberation, 44.8 (16.6) versus 32.8 (15.9), P = .002; background noise, 55.5 (23.6) versus 35.2 (18.1), P < .001; and aversiveness, 36.7 (22.8) versus 25.8 (21.4), P = .028. Moreover, the THI scores were significantly reduced [47.4 (30.1) versus 31.1 (27.0), P = .003]. Congenital SSD was a significant factor of subjective benefit (−11.643; 95% confidence interval: −21.946 to −1.340).

Conclusion

The BCI602 active transcutaneous BCI device can provide functional hearing gain without any adverse effects and is a feasible option for acquired SSD patients with long‐term deafness.

Subjects

MeSH terms (MEDLINE)

DeafnessHearing AidsTinnitusSpeech PerceptionAdultHumansProspective StudiesBone ConductionHearingTreatment Outcome

Author keywords

active transcutaneous bone conduction implantbone conduction implantbonebridgesingle-sided deafness

Authors and institutions

  • Department of Otorhinolaryngology-Head and Neck Surgery, Konyang University College of Medicine, Daejeon, Korea.
  • Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Otorhinolaryngology-Head and Neck Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Department of Otolaryngology-Head and Neck Surgery, Chonnam National University Medical School and Chonnam National University Hospital, Gwangju, Korea.
  • Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Seoul Hospital, Seoul, Korea.

ORCID profiles: Hantai Kim, Moo Kyun Park, Shi Nae Park, Hyong-Ho Cho, Jae Young Choi, Chi Kyou Lee, Il Joon Moon, Jae Yun Jung, Jinsei Jung, Hong Ju Park, Jae-Hyun Seo, Jae-Jin Song, Jungho Ha, Jeong Hun Jang, Yun-Hoon Choung

Cite

APA

Kim, H., Park, M. K., Park, S. N., Cho, H. H., Choi, J. Y., Lee, C. K., Lee, I. W., Moon, I. J., Jung, J. Y., Jung, J., Lee, K. Y., Oh, J. H., Park, H. J., Seo, J. H., Song, J. J., Ha, J., Jang, J. H., & Choung, Y. H. (2024). Efficacy of the Bonebridge BCI602 for Adult Patients with Single‐sided Deafness: A Prospective Multicenter Study. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.520

Vancouver

Kim H, Park MK, Park SN, Cho HH, Choi JY, Lee CK, et al. Efficacy of the Bonebridge BCI602 for Adult Patients with Single‐sided Deafness: A Prospective Multicenter Study. Otolaryngology–Head and Neck Surgery. 2024. doi:10.1002/ohn.520

BibTeX
@article{Kim2024,
  author = {Kim, Hantai and Park, Moo Kyun and Park, Shi Nae and Cho, Hyong-Ho and Choi, Jae Young and Lee, Chi Kyou and Lee, Il-Woo and Moon, Il Joon and Jung, Jae Yun and Jung, Jinsei and Lee, Kyu-Yup and Oh, Jeong-Hoon and Park, Hong Ju and Seo, Jae-Hyun and Song, Jae-Jin and Ha, Jungho and Jang, Jeong Hun and Choung, Yun-Hoon},
  title = {Efficacy of the Bonebridge BCI602 for Adult Patients with Single‐sided Deafness: A Prospective Multicenter Study},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2024},
  doi = {10.1002/ohn.520}
}
Start for free →